Pancreatic islet transplantation has become an established approach to β-cell replacement
therapy for the treatment of insulin-deficient diabetes. Recent progress in techniques for islet …

Type 1 diabetes (T1D) presents a persistent medical challenge, demanding innovative
strategies for sustained glycemic control and enhanced patient well-being. Beta cells are …

Evidence suggests associations between COVID-19 patients or vaccines and
glycometabolic dysfunction and an even higher risk of the occurrence of diabetes. Herein …

Islet transplantation stabilizes glycemic control in patients with complicated diabetes
mellitus. Rapid functional decline could be due to islet allograft rejection. However, there is …

Intraportal (IP) islet cell transplants can restore metabolic control in type 1 diabetes patients,
but limitations raise the need for establishing a functional beta cell mass (FBM) in a confined …

Aims/hypothesis The initial avascular period following islet transplantation seriously
compromises graft function and survival. Enhancing graft revascularisation to improve …

Allogeneic islet transplantation has vastly improved over the past two decades. Success in
restoration of glycemic control and hypoglycemic awareness after islet transplantation has …

Despite recent advances, insulin therapy remains a treatment, not a cure, for diabetes
mellitus with persistent risk of glycaemic alterations and life‐threatening complications …

Aim Several biomarkers have been proposed to detect pancreatic β cell destruction in vivo
but so far have not been compared for sensitivity and significance. Methods We used islet …

Introduction: Patients presenting with diabetic ketoacidosis (DKA) who lack the classic
phenotype of autoimmune type 1 diabetes have become increasingly identified in recent …